SGPL1 and neuroblastoma: Studies on the in vitro PD model, namely the human neuroblastoma cell line (SH-SY5Y) treated with a neurotoxin 1-methyl-4-phenylpyridinium (MPP+), showed a significant increase in mRNA level of SPL and SphK2 together with decreased gene expression of SphK1 [100].